COGNICURRENT

Jan 8 • 00:30 UTC • 🇨🇳 China • South China Morning Post

Chinese drug makers strike a record US$136 billion in out-licensing deals in 2025

Chinese drug makers achieved a historic US$136 billion in out-licensing agreements in 2025, more than doubling the previous year's total with 157 deals signed.

#china #pharmaceuticals #licensing #out-licensing #deals

Read Original Back to Feed

📡 Similar Coverage

🇨🇳 China Feb 10 • 05:00 UTC

Chinese investors pour into Hong Kong-listed drug stocks as international deals multiply

South China Morning Post

🇨🇳 China Feb 6 • 09:00 UTC

Fosun Pharma’s US$1.55 billion Eisai deal signals shift to long-term partnerships

South China Morning Post

🇨🇳 China Jan 13 • 05:11 UTC

China’s SciNeuro, Novartis sign US$1.7 billion licensing deal to develop Alzheimer’s drugs

South China Morning Post

🇨🇳 China Jan 2 • 22:00 UTC

China’s biopharma sector ‘in prime position to challenge US leadership’

South China Morning Post

🇫🇷 France Jan 14 • 09:56 UTC

China sees record $1.19 trillion trade surplus in 2025 in spite of US tariffs

France24

🇳🇬 Nigeria Feb 4 • 14:04 UTC

UK, US drug pricing deal to cost £1bn over three years

Punch